Sg3 Management, LLC Mannkind Corp Put Options Transaction History

Sg3 Management, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 15, 2022	BUY	$2.67 - $4.77 $80,100 - $143,100	30,000 New	30,000 $114,000
Q1 2018 May 11, 2018	SELL	$2.28 - $3.8 $91,199 - $152,000	-40,000 Closed	0 $0
Q4 2017 Feb 26, 2018	BUY	$2.28 - $6.71 $90,287 - $265,716	39,600 Added 9900.0%	40,000 $93,000
Q4 2017 Feb 13, 2018	BUY	$2.28 - $6.71 $911 - $2,684	400	400 $110,000

245

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.75B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.